Latest Conference Articles

In this clip, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, compares the use of premixed with compound IV products for enhanced patient safety.

The new section will provide an enhanced focus on ASHP’s efforts to help its members provide optimal patient care and comprehensive medication therapy management in the specialty pharmacy environment.

Pharmacists have a crucial role to play in identifying medication safety issues and implementing best practices to prevent errors, according to the ISMP.

In this clip, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, discusses the features and functionalities to consider when purchasing a new infusion pump.

Leticia Shea, PharmD, BCACP, Associate Professor of Pharmacy at Regis University, discusses why it's important for pharmacists to educate patients on medical cannabis use.

Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, talks about the benefits of using ready-to-use, premixed IV products versus compound IV products.

Sponsored by ASHP and the ASHP Research and Education Foundation, the award honors student members in their second through fourth professional years of pharmacy school.

Our team is on site in Denver all week covering from ASHP Summer 2018.

In this clip, Traci Fritschle, PharmD, explains why pharmacists are uniquely positioned to be utilized in a team-based model for diabetes care.

At the American Pharmacists Association Annual Meeting, Lucinda L. Maine, PhD, RPh, AACP, was honored with the Gloria Niemeyer Francke Leadership Mentor Award.

In Idaho, pharmacists are able to delegate tasks, such as final product verification, transferring prescriptions, and even administering vaccines, to pharmacy technicians.

In this clip, Brooke Griffin, PharmD, from Midwestern University, discusses the pharmacist's role in assessing patient eligibility for hormonal contraception.

In a session at APhA2018, the national president of the American Pharmacists Association Academy of Student Pharmacists, spoke about organizing events, such as a flu vaccine clinic or presentation.

Following NDPP guidelines for early prevention programs, The Kroger Co. established patient-centered processed that involved collecting and assessing patient records, while connecting those enrolled in the study with lifestyle coaches.

Assure patients they'll be able to forward their medications, and counsel on how to administer them.

Two pharmacy professors address this issue in a session at APhA2018 called "Loosening Controls on Birth Control: Helping Women Get the Care They Need."

WellDyneRx has created a comprehensive program to control costs while improving communication and outcomes.

The recipients of the 2018 APhA Immunization Champion Awards have been announced

She is director of the Bristol-Myers Squibb Foundation, which works to promote health equity and improve the health outcomes of those disproportionately affected by serious conditions and diseases.

The APhA annual meeting is about to kick off, and we will be there all weekend covering it live.

Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.

Kohei Shitara, MD, Department of Gastrointestinal Oncology of National Cancer Center Hospital East, Japan, discusses the importance of the REVERCE clinical trial for specialty pharmacists.

Prior treatment with sorafenib followed by pembrolizumab (Keytruda) shows promising progression-free survival and overall survival in patients with advanced hepatocellular carcinoma.

Cetuximab (Erbitux) with pembrolizumab (Keytruda) shows promise in patients with mCRC.

Induction therapy shows the potential to achieve disease control in patients with locally advanced pancreatic cancer.

A novel CTC assay showed up to 88% accuracy detecting precancerous and cancerous colorectal lesions.

Nivolumab (Opdivo) alone and in combination with ipilimumab (Yervoy) induced responses in patients with heavily pretreated gastrointestinal stromal tumors.

The addition of ramucirumab did not improve overall survival in patients with HER2-negative gastric cancer.